Literature DB >> 29967998

Biomarkers in Neuropsychiatry: A Prospect for the Twenty-First Century?

Judith Pratt1, Jeremy Hall2.   

Abstract

The search for biomarkers to aid in the diagnosis and prognosis of psychiatric conditions and predict response to treatment is a focus of twenty-first century medicine. The current lack of biomarkers in routine use is attributable in part to the existing way mental health conditions are diagnosed, being based upon descriptions of symptoms rather than causal biological evidence. New ways of conceptualizing mental health disorders together with the enormous advances in genetic, epidemiological, and neuroscience research are informing the brain circuits and physiological mechanisms underpinning behavioural constructs that cut across current diagnostic DSM-5 categories. Combining these advances with 'Big Data', analytical approaches offer new opportunities for biomarker development. Here we provide an introductory perspective to this volume, highlighting methodological strategies for biomarker identification; ranging from stem cells, immune mechanisms, genomics, imaging, network science to cognition. Thereafter we emphasize key points made by contributors on affective disorders, psychosis, schizophrenia, and autism spectrum disorder. An underlying theme is how preclinical and clinical research are informing biomarker development and the importance of forward and reverse translation approaches. In considering the exploitation of biomarkers we note that there is a timely opportunity to improve clinical trial design informed by patient 'biological' and 'psychological' phenotype. This has the potential to reinvigorate drug development and clinical trials in psychiatry. In conclusion, we are poised to move from the descriptive and discovery phase to one where biomarker panels can be evaluated in real-life cohorts. This will necessitate resources for large-scale collaborative efforts worldwide. Ultimately this will lead to new interventions and personalized medicines and transform our ability to prevent illness onset and treat complex psychiatric disorders more effectively.

Entities:  

Keywords:  Affective disorders; Autism spectrum disorder; Diagnostic biomarker; Early intervention; Forward and reverse translation; Genetics; Genomics; Immune; Inflammation; Patient stratification; Personalized medicines; Predictive biomarker; Prognosis biomarker; Psychosis; Schizophrenia; Stem cells

Mesh:

Substances:

Year:  2018        PMID: 29967998     DOI: 10.1007/7854_2018_58

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  7 in total

Review 1.  Recent advancements in biomarker research in schizophrenia: mapping the road from bench to bedside.

Authors:  Shivangi Patel; Dilip Sharma; Ankit Uniyal; Anagha Gadepalli; Vinod Tiwari
Journal:  Metab Brain Dis       Date:  2022-03-03       Impact factor: 3.655

Review 2.  Stem cell therapy in autism: recent insights.

Authors:  Dario Siniscalco; Suresh Kannan; Neomar Semprún-Hernández; Adrien A Eshraghi; Anna Lisa Brigida; Nicola Antonucci
Journal:  Stem Cells Cloning       Date:  2018-10-23

3.  Maternal environmental risk factors and the development of internalizing and externalizing problems in childhood: The complex role of genetic factors.

Authors:  Judith B M Ensink; Marleen H M de Moor; Mohammad Hadi Zafarmand; Sanne de Laat; André Uitterlinden; Tanja G M Vrijkotte; Ramón Lindauer; Christel M Middeldorp
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-08-24       Impact factor: 3.568

4.  Drug development post COVID-19 pandemic: toward a better system to meet current and future global health challenges.

Authors:  Koippallil Gopalakrishnan Aghila Rani; Mohamad A Hamad; Dana M Zaher; Scott McN Sieburth; Navid Madani; Taleb H Al-Tel
Journal:  Expert Opin Drug Discov       Date:  2020-12-28       Impact factor: 6.098

5.  Adaptation and validation of a computerized neurocognitive battery in the Xhosa of South Africa.

Authors:  J Cobb Scott; Tyler M Moore; Dan J Stein; Adele Pretorius; Zukiswa Zingela; Mohammed Nagdee; Linda Ngqengelele; Megan Campbell; Goodman Sibeko; Mary Claire King; Jon M McClellan; Allison M Port; Chad Jackson; Kosha Ruparel; Ezra S Susser; Ruben C Gur
Journal:  Neuropsychology       Date:  2021-07-05       Impact factor: 3.424

6.  Finding specificity in structural brain alterations through Bayesian reverse inference.

Authors:  Franco Cauda; Andrea Nani; Donato Liloia; Jordi Manuello; Enrico Premi; Sergio Duca; Peter T Fox; Tommaso Costa
Journal:  Hum Brain Mapp       Date:  2020-08-23       Impact factor: 5.399

7.  Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning.

Authors:  Giulia M Giordano; Luigi Giuliani; Andrea Perrottelli; Paola Bucci; Giorgio Di Lorenzo; Alberto Siracusano; Francesco Brando; Pasquale Pezzella; Michele Fabrazzo; Mario Altamura; Antonello Bellomo; Giammarco Cascino; Anna Comparelli; Palmiero Monteleone; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.